UST Sentro sa Salin translates app into Filipino
VigiMobile is also designed to strengthen post-market surveillance for medicines, vaccines, and other health products.
Department of Nutrition and Dietetics chair assistant professor Kathleen Cruzada, SSAS chair associate professor Wennielyn Fajilan, PhD, Center for Drug Regulation and Research director IV Maria Cecilia Matienzo, Pharmacovigilance Section head Mark Ryann Lirasan, FDA Philippines director general Dr. Samuel Zacate and professor Amalia Castro, LPT, PhD.
Photograph courtesy of The Vigimobile app
UST Sentro sa Salin at Araling Salin translation council members partnered with the Food and Drug Administration in translating the government agency’s VigiMobile app into Filipino.
Launched on 21 October 2024, VigiMobile is a mobile application that enables healthcare professionals, consumers, patients and the public to report suspected adverse drug reactions directly, enhancing the FDA’s capacity for health product monitoring.
VigiMobile is also designed to strengthen post-market surveillance for medicines, vaccines, and other health products.
The team included Charlotte Malinao, LPT, MA, who translated the text, assoc. prof. Amalia M. Castro, LPT, PhD, who served as the language evaluator and UST SSAS chair assoc. prof. Wennielyn F. Fajilan, PhD, as the adjudicator. They were joined by FDA Philippines’ Julia Anne Capuchino, the team’s content evaluator and Mark Ryann Lirasan, head of the agency’s Pharmacovigilance Section of the Center for Drug Regulation and Research.
The project was coordinated in partnership with the World Health Organization.